Biocon to consider and approve unaudited quarterly Q3 results

08 Jan 2013 Evaluate
Biocon has informed that a meeting of the Board of directors of the company will be held on January 24, 2013, to consider and approve the unaudited financial results of the company for the quarter ended December 31, 2012.

The above information is a part of company’s filings submitted to BSE.

Biocon Share Price

376.00 -1.55 (-0.41%)
19-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.55
Dr. Reddys Lab 1166.45
Cipla 1391.20
Zydus Lifesciences 881.10
Lupin 2178.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×